You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • SAT0294 Circulating LIN1-DABP-CD34+CD133+CD309+ Endothelial Progenitor Cells (EPC) Are Reduced in Patients with Systemic Lupus Erythematosus (SLE) but Not Associated with Biophysical Markers of Cardiovascular Disease (CVD)

Article info

Article menu
Download PDFPDF
Poster Presentations
SLE, Sjögren's and APS - clinical aspects (other than treatment)
SAT0294 Circulating LIN1-DABP-CD34+CD133+CD309+ Endothelial Progenitor Cells (EPC) Are Reduced in Patients with Systemic Lupus Erythematosus (SLE) but Not Associated with Biophysical Markers of Cardiovascular Disease (CVD)

Authors

Citation

Mak A, Ling L, Kow N, et al
SAT0294 Circulating LIN1-DABP-CD34+CD133+CD309+ Endothelial Progenitor Cells (EPC) Are Reduced in Patients with Systemic Lupus Erythematosus (SLE) but Not Associated with Biophysical Markers of Cardiovascular Disease (CVD)
Annals of the Rheumatic Diseases 2016;75:774-775.

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions